multiple myelomaMMbortezomibDexamethasonesalubrinalDXMdaratumumab-mediated
…d producing type I interferons, but is frequently suppressed in multiple myeloma (MM), enabling immune evasion. Dexamethasone (DXM), a cornersto…
16articles mentioning diseases
34disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: MM ×
MM
This disease is selected. Its supporting articles are shown below.
Articles mentioning MM
16 articles · page 1 of 2lymphomamultiple myelomaacute leukaemiaMMhaematologic malignanciesALchronic kidney failure
…moderate validity in AL (r=0.386, p=0.002) and poor validity in lymphoma (r=0.230, p=0.129). In patients with AL, chronic kidney failure…
multiple myelomaMMLTG3551cilta-celNew England Journal of Medicineciltacabtagene autoleucelIde-celidecabtagene vicleucel
…lis NJ. Ide-cel or standard regimens in relapsed and refractory multiple myeloma. New England Journal of Medicine. 2023 Mar 16;388(11):1002-14.V…
MM
…y according to definitions of MM employed, with mental-physical MM showing a different pattern from the other definitions, which h…
MMcutaneous squamous cell carcinomaCSCCPegenzileukincemiplimabpembrolizumab
… multicenter study evaluated drug combinations in patients with MM (Cohort A) and CSCC (Cohort B). Pegenzileukin was given at two …
multiple myelomaDLBCLacute lymphoblastic leukaemiadiffuse large B-cell lymphomaICANSMMALLcytokine release syndromeimmune effector cell-associated neurotoxicity syndrome (ICANS)
…= 53, 76%), acute lymphoblastic leukaemia (ALL, n = 6, 9%), and multiple myeloma (MM, n = 6, 9%). CAR-T products: axicabtagene ciloleucel (n = 3…
multiple myelomaMMBsAbBsAbssix academic institutions
…er, the impact of antibiotic-induced dysbiosis in patients with multiple myeloma (MM) treated with bispecific antibodies (BsAbs) remains unexplo…
malignant melanomaMMPDARO
…NILs) following radiotherapy (RT), is relevant in patients with malignant melanoma (MM) with progressive disease (PD) under immune checkpoint inhi…
multiple myelomaacute myeloid leukemiaMDSCD1d-expressing hematological malignanciesAMLMMlenalidomideIMiD
… cells to CD1d-expressing hematological malignancies, including multiple myeloma (MM) and acute myeloid leukemia (AML). Here, we evaluated wheth…
multiple myelomaMM177LuABDB6177Lu]Lu-DOTA-ABDB6Lu-DOTA-ABDB6CD70CD70-targeted89Zr
…Background CD70, overexpressed in multiple myeloma (MM), is a promising target for theranostics. This study develo…
Multiple myelomaNDMMMMdaratumumablenalidomidebortezomibmelphalanprednisonedexamethasoneAnn Oncol+3 more
…5:10.1038/s41375-024-02506-1.3. Dimopoulos MA, Moreau P, et al. Multiple myeloma: EHA-ESMO Clinical Practice Guidelines. Ann Oncol. 2021;32(3):3…